Back to search

Axovia Therapeutics Ltd

14715294

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

78 PALL MALL, LONDON, SW1Y 5ES
Incorporated 08/03/2023

Compliance

Last accounts

31/12/2025

unaudited abridged

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 07/03/2026

Due 21/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Alek Safarian

director · Since 08/03/2023

CHIEF EXECUTIVE

AUSTRALIAN · UNITED STATES · Age 61

Also on 4 other boards

Dr Robert Henry Balfour

director · Since 24/05/2023

INVESTMENT DIRECTOR

BRITISH · ENGLAND · Age 46

Also on 2 other boards

Mr Bruce Aoki Goldsmith

director · Since 03/02/2025

CONSULTANT

AMERICAN · UNITED STATES · Age 60

Persons with Significant Control

Mr Alek Safarian

50–75% shares
50–75% votes
Appoint directors

Australian · United States · Age 61

78, Pall Mall, London, SW1Y 5ES

Notified 08/03/2023

Alsa Ventures I Scsp

75–100% shares

33, 33 Avenue J F Kennedy, Luxembourg - Kirchberg

Reg: B243238 · Luxembourg Company Register · Limited Partnership

Notified 12/05/2023

Charges0 outstanding

Charge
satisfied

HSBC INNOVATION BANKING

Created 27/02/2025Registered 27/02/2025Satisfied 06/03/2026
Charge
satisfied

HSBC INNOVATION BANKING

Created 18/10/2023Registered 20/10/2023Satisfied 06/03/2026
Charge
satisfied

HSBC INNOVATION BANKING

Created 05/10/2023Registered 20/10/2023Satisfied 04/03/2025

CompanyRankvs 347+ SIC 72110 peers
76

Financial strength96th percentile among SIC peers · 24/25
Employees90th percentile among SIC peers · 14/15
LiquidityCurrent ratio 12.99× · 20/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
347Axovia Therapeutics Ltd
76
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£3.2M

Balance sheet strength

Cash

£2.7M

Cash in the bank

Net Current Assets

£2.9M

Working capital

Current Assets

£3.1M

Current Liabilities

£239k

Fixed Assets

£645k

Debtors

£418k

8avg. employees

Balance Sheet

Assets less current liabilities£3.5M
Signed by 2025-01-01Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
202512.99+£2.9M
202438.74-£1.5M
202312.24—

Derived from filed accounts. Not audited figures.